45
Participants
Start Date
July 22, 2024
Primary Completion Date
July 22, 2029
Study Completion Date
July 22, 2029
DANYELZA
DANYELZA is a humanized monoclonal antibody of the IgG1 subclass
Sargramostim
Yeast derived recombinant human Sargramostim (GM-CSF)
Cytoxan
Cyclophosphamide is an alkylating agent related to nitrogen mustard
Topotecan
Topotecan is a topoisomerase I-inhibitor that is a semisynthetic derivative of camptothecin.
Vincristine
Vincristine is an alkaloid isolated from Vinca rosea Linn (periwinkle).
Doxorubicin
Doxorubicin is an anthracycline antibiotic
Ifosfamide
Ifosfamide is a structural analogue of cyclophosphamide
Etoposide
Etoposide for Injection is available as a 20 mg/mL solution in sterile multiple dose vials (5 mL, 25 mL, or 50 mL each).
Carboplatin
Carboplatin is available in 50 mg, 150 mg, 450 mg, and 600 mg vials.
Irinotecan
Irinotecan hydrochloride trihydrate (CPT-11) is a topoisomerase I inhibitor
Temozolomide
Temozolomide is administered intravenously
RECRUITING
Memorial Sloan Kettering Cancer Center, New York
Memorial Sloan Kettering Cancer Center
OTHER